TZM interferes with the RAAS system via the upregulation of angiotensin II (ANG II), resulting in increased oxidative stress in the heart and endothelial cells, endothelial dysfunction, and cardiomyocyte apoptosis [120,121]. The gene discussed is AGT; the disease is endothelial dysfunction.